Robb Rydzynski
Obstetrics & Gynecology · Dixon, ILNPI 1720016306
Payments from drug & device makers
Across 157 payments — averaging $42.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$3K
- Axonics, Inc.$728
- AbbVie$497
- Pfizer$361
- Mayne Pharma Commercial LLC$353
- Astellas Pharma US Inc$287
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$2734%
- Food & beverage$3,00445%
- Education$3,44651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 7 | $3,440 |
| Axonics, Inc. | 24 | $728 |
| AbbVie(2 entities) | 28 | $497 |
| Pfizer | 28 | $361 |
| Mayne Pharma Commercial LLC | 1 | $353 |
| Astellas Pharma US Inc | 12 | $287 |
| Sumitomo Pharma America, Inc. | 7 | $149 |
| Myovant Sciences Inc. | 6 | $114 |
| Therapeuticsmd, Inc. | 5 | $90 |
| Novo Nordisk | 5 | $80 |
| Johnson & Johnson | 1 | $58 |
| Organon | 4 | $56 |
| Boston Scientific | 3 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Organogenesis Inc. | 2 | $38 |
| Bayer | 2 | $36 |
| Convatec Inc. | 2 | $33 |
| Amgen | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Lilly USA, LLC | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Davol Inc. | 1 | $22 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Urovant Sciences Inc | 1 | $20 |
| Merck | 1 | $18 |
| Medtronic | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Dysis Medical, Inc. | 1 | $16 |
| Acessa Health Inc. | 1 | $15 |
| Minerva Surgical, Inc | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Ambu Inc. | 1 | $14 |
| Aspira Women's Health Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,723 in reported general payments places this provider in the 90th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 31 | $19,549 |
| GemtesaVibegron | 16 | $13,488 |
| ImvexxyEstradiol | 17 | $4,405 |
| Solifenacin Succinate | 42 | $1,361 |
| Estradiol | 19 | $1,217 |
| ValacyclovirValacyclovir Hcl | 20 | $407 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $316 |
| Levofloxacin | 35 | $179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $156 |
| Ciprofloxacin Hcl | 11 | $83 |
| Cephalexin | 18 | $78 |
| Tamsulosin Hcl | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $287 | $19,54931 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $149 | $13,48816 claims |
| Therapeuticsmd, Inc.Imvexxy | $90 | $4,40517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Other obstetrics & gynecology in Dixon
- Phyllis MarxSkokie$2M
- Mary Jenkins VogelEvanston$886K
- Charles MillerNaperville$603K
- Lee ShulmanChicago$577K
- Anne SchaibleOak Lawn$546K
- Christopher OlsonNaperville$530K
- Laura PearlmanSkokie$426K
- Maria TamChicago$378K
- Amy WhitakerChicago$351K
- Gregory UrsinoChicago$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.